SKI Market

A+| A| A-|

Indian Indices

Sensex

74,234.15 127.30
( 0.17%)

Global Indices

Nasdaq

46,689.37 163.69
(0.35%)

Dow Jones

6,632.05 28.36
(0.43%)

Hang Seng

53,529.44 115.76
(0.22%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

92.68 -0.34
(-0.37%)

EUR-INR

106.73 -0.59
(-0.55%)

GBP-INR

122.22 -0.80
(-0.65%)

JPY-INR

0.58 0.00
(-0.50%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5542386

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

21.18

97022.77

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.33

Back

jm financial credit solutions ltd

Embassy Developments reports consolidated net loss of Rs 233.14 crore in the December 2025 quarter

Feb 10,2026

Net Loss of Embassy Developments reported to Rs 233.14 crore in the quarter ended December 2025 as against net loss of Rs 21.19 crore during the previous quarter ended December 2024. Sales declined 34.70% to Rs 212.40 crore in the quarter ended December 2025 as against Rs 325.29 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	212.40	325.29	-35
OPM %	-71.75	28.90	-
PBDT	-214.24	-8.43	-2441
PBT	-234.26	-11.23	-1986
NP	-233.14	-21.19	-1000

74,234.15 127.30 ( 0.17%)

46,689.37 163.69 (0.35%)

6,632.05 28.36 (0.43%)

53,529.44 115.76 (0.22%)

10,436.29 71.50 (0.69%)

92.68 -0.34 (-0.37%)

106.73 -0.59 (-0.55%)

122.22 -0.80 (-0.65%)

0.58 0.00 (-0.50%)